[1] ASSADSANGABI A, EVANS CA, CORFE BM, et al. Application of Proteomics to Inflammatory Bowel Disease Research: Current Status and Future Perspectives. Gastroenterol Res Pract. 2019;2019: 1426954.
[2] MANNINEN P, KARVONEN AL, HUHTALA H, et al. Mortality in ulcerative colitis and Crohn's disease. A population-based study in Finland. J Crohns Colitis. 2012;6(5):524-528.
[3] HANSEN R, THOMSON JM, EL-OMAR EM, et al. The role of infection in the aetiology of inflammatory bowel disease. J Gastroenterol. 2010; 45(3):266-276.
[4] KABAT AM, POTT J, MALOY KJ. The Mucosal Immune System and Its Regulation by Autophagy. Front Immunol. 2016;7:240.
[5] EBBO M, CRINIER A, VÉLY F, et al. Innate lymphoid cells: major players in inflammatory diseases. Nat Rev Immunol. 2017;17(11): 665-678.
[6] SHIN HR, KIM H, KIM KI, et al. Epigenetic and transcriptional regulation of autophagy. Autophagy. 2016;12(11):2248-2249.
[7] HUANG H, FANG M, JOSTINS L, et al. Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature. 2017;547(7662): 173-178.
[8] IIDA T, YOKOYAMA Y, WAGATSUMA K, et al. Impact of Autophagy of Innate Immune Cells on Inflammatory Bowel Disease. Cells. 2018;8(1): E7.
[9] KROEMER G, MARIÑO G, LEVINE B. Autophagy and the integrated stress response. Mol Cell. 2010;40(2):280-293.
[10] NETEA-MAIER RT, PLANTINGA TS, VAN DE VEERDONK FL, et al. Modulation of inflammation by autophagy: Consequences for human disease. Autophagy. 2016;12(2):245-260.
[11] BRÜNE B, DEHNE N, GROSSMANN N, et al. Redox control of inflammation in macrophages. Antioxid Redox Signal. 2013;19(6):595-637.
[12] WU Y, YAO J, XIE J, et al. The role of autophagy in colitis-associated colorectal cancer. Signal Transduct Target Ther. 2018;3:31.
[13] PERAL DE CASTRO C, JONES SA, NÍ CHEALLAIGH C, et al. Autophagy regulates IL-23 secretion and innate T cell responses through effects on IL-1 secretion. J Immunol.2012;189(8): 4144-4153.
[14] GOLDBERG R, PRESCOTT N, LORD GM, et al. The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD. Nat Rev Gastroenterol Hepatol. 2015;12(5):271-283.
[15] CULLEN TW, SCHOFIELD WB, BARRY NA, et al. Gut microbiota. Antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation. Science. 2015;347(6218):170-175.
[16] CADWELL K, LIU JY, BROWN SL, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature. 2008;456(7219):259-263.
[17] TAKAHASHI N, VANLAERE I, DE RYCKE R, et al. IL-17 produced by Paneth cells drives TNF-induced shock. J Exp Med. 2008;205(8): 1755-1761.
[18] ITOH H, BECK PL, INOUE N, et al. A paradoxical reduction in susceptibility to colonic injury upon targeted transgenic ablation of goblet cells. J Clin Invest. 1999;104(11):1539-1547.
[19] MIZUSHIMA N, NODA T, YOSHIMORI T, et al. A protein conjugation system essential for autophagy. Nature. 1998;395(6700):395-398.
[20] VANDUSSEN KL, LIU TC, LI D, et al. Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of Crohn's disease. Gastroenterology. 2014;146(1):200-209.
[21] ZHANG H, ZHENG L, CHEN J, et al. The protection role of Atg16l1 in CD11c+dendritic cells in murine colitis. Immunobiology. 2017;222(7): 831-841.
[22] WILDENBERG ME, VOS AC, WOLFKAMP SC, et al. Autophagy attenuates the adaptive immune response by destabilizing the immunologic synapse. Gastroenterology. 2012;142(7):1493-1503.e6.
[23] CADWELL K, PATEL KK, KOMATSU M, et al. A common role for Atg16L1, Atg5 and Atg7 in small intestinal Paneth cells and Crohn disease. Autophagy. 2009;5(2):250-252.
[24] ADOLPH TE, TOMCZAK MF, NIEDERREITER L, et al. Paneth cells as a site of origin for intestinal inflammation. Nature. 2013;503(7475): 272-276.
[25] GRÉGOIRE IP, RABOURDIN-COMBE C, FAURE M. Autophagy and RNA virus interactomes reveal IRGM as a common target. Autophagy. 2012;8(7):1136-1137.
[26] CHAUHAN S, MANDELL MA, DERETIC V. IRGM governs the core autophagy machinery to conduct antimicrobial defense. Mol Cell. 2015;58(3):507-521.
[27] FENG CG, WEKSBERG DC, TAYLOR GA, et al. The p47 GTPase Lrg-47 (Irgm1) links host defense and hematopoietic stem cell proliferation. Cell Stem Cell. 2008;2(1):83-89.
[28] LIU B, GULATI AS, CANTILLANA V, et al. Irgm1-deficient mice exhibit Paneth cell abnormalities and increased susceptibility to acute intestinal inflammation. Am J Physiol Gastrointest Liver Physiol. 2013;305(8):G573-584.
[29] BEN-AVRAHAM D, MUZUMDAR RH, ATZMON G. Epigenetic genome-wide association methylation in aging and longevity. Epigenomics. 2012;4(5):503-509.
[30] LOW D, MIZOGUCHI A, MIZOGUCHI E. DNA methylation in inflammatory bowel disease and beyond. World J Gastroenterol. 2013;19(32):5238-5249.
[31] WIENHOLZ BL, KARETA MS, MOAREFI AH, et al. DNMT3L modulates significant and distinct flanking sequence preference for DNA methylation by DNMT3A and DNMT3B in vivo. PLoS Genet. 2010;6(9):e1001106.
[32] PANCHOLI S, LYKKESFELDT AE, HILMI C, et al. ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2. Endocr Relat Cancer. 2008;15(4):985-1002.
[33] JONES B, CHEN J. Inhibition of IFN-gamma transcription by site-specific methylation during T helper cell development. EMBO J. 2006;25(11):2443-2452.
[34] KRAICZY J, NAYAK K, ROSS A, et al. Assessing DNA methylation in the developing human intestinal epithelium: potential link to inflammatory bowel disease. Mucosal Immunol. 2016;9(3):647-658.
[35] NIMMO ER, PRENDERGAST JG, ALDHOUS MC, et al. Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway. Inflamm Bowel Dis. 2012;18(5):889-899.
[36] TAMAN H, FENTON CG, HENSEL IV, et al. Genome-wide DNA Methylation in Treatment-naïve Ulcerative Colitis. J Crohns Colitis. 2018;12(11):1338-1347.
[37] LUGER K, MÄDER AW, RICHMOND RK, et al. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature. 1997;389(6648): 251-260.
[38] RANSOM M, DENNEHEY BK, TYLER JK. Chaperoning histones during DNA replication and repair. Cell. 2010;140(2):183-195.
[39] ROOSTAEE A, BENOIT YD, BOUDJADI S, et al. Epigenetics in Intestinal Epithelial Cell Renewal. J Cell Physiol. 2016;231(11):2361-2367.
[40] GARCIA-PETERSON LM, NDIAYE MA, SINGH CK, et al. SIRT6 histone deacetylase functions as a potential oncogene in human melanoma. Genes Cancer. 2017;8(9-10):701-712.
[41] LO SASSO G, MENZIES KJ, MOTTIS A, et al. SIRT2 deficiency modulates macrophage polarization and susceptibility to experimental colitis. PLoS One. 2014;9(7):e103573.
[42] SHIN HJ, KIM H, OH S, et al. AMPK-SKP2-CARM1 signalling cascade in transcriptional regulation of autophagy. Nature. 2016;534(7608): 553-557.
[43] DECHASSA ML, SABRI A, PONDUGULA S, et al. SWI/SNF has intrinsic nucleosome disassembly activity that is dependent on adjacent nucleosomes. Mol Cell. 2010;38(4):590-602.
[44] HOTA SK, BRUNEAU BG. ATP-dependent chromatin remodeling during mammalian development. Development. 2016;143(16):2882-2897.
[45] HALL JA, GEORGEL PT. CHD proteins: a diverse family with strong ties. Biochem Cell Biol. 2007;85(4):463-476.
[46] LE GUEZENNEC X, VERMEULEN M, BRINKMAN AB, et al. MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Mol Cell Biol. 2006;26(3): 843-851.
[47] YAMADA T, YANG Y, HEMBERG M, et al. Promoter decommissioning by the NuRD chromatin remodeling complex triggers synaptic connectivity in the mammalian brain. Neuron. 2014;83(1):122-134.
[48] PAPAMICHOS-CHRONAKIS M, WATANABE S, RANDO OJ, et al. Global regulation of H2A.Z localization by the INO80 chromatin- remodeling enzyme is essential for genome integrity. Cell. 2011; 144(2):200-213.
[49] KALITSIS P, ZHANG T, MARSHALL KM, et al. Condensin, master organizer of the genome. Chromosome Res. 2017;25(1):61-76.
[50] RANKIN S, DAWSON DS. Recent advances in cohesin biology. F1000Res. 2016;5. pii: F1000 Faculty Rev-1909.
[51] WEBER MJ. New human and mouse microRNA genes found by homology search. FEBS J. 2005;272(1):59-73.
[52] WANG J, YANG K, ZHOU L, et al. MicroRNA-155 promotes autophagy to eliminate intracellular mycobacteria by targeting Rheb. PLoS Pathog. 2013;9(10):e1003697.
[53] EVEL-KABLER K, SONG XT, ALDRICH M, et al. SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling. J Clin Invest. 2006;116(1):90-100.
[54] WU H, NEILSON JR, KUMAR P, et al. miRNA profiling of naïve, effector and memory CD8 T cells. PLoS One. 2007;2(10):e1020.
[55] ZHAI Z, WU F, DONG F, et al. Human autophagy gene ATG16L1 is post-transcriptionally regulated by MIR142-3p. Autophagy. 2014;10(3): 468-479.
[56] LI Y, ZHOU D, REN Y, et al. Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1. Autophagy. 2019;15(3): 478-492.
[57] HUANG Y, CHUANG AY, RATOVITSKI EA. Phospho-ΔNp63α/miR- 885-3p axis in tumor cell life and cell death upon cisplatin exposure. Cell Cycle. 2011;10(22):3938-3947.
[58] LU C, CHEN J, XU HG, et al. MIR106B and MIR93 prevent removal of bacteria from epithelial cells by disrupting ATG16L1-mediated autophagy. Gastroenterology. 2014;146(1):188-199.
[59] WU F, GUO NJ, TIAN H, et al. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 2011; 17(1):241-250.
[60] TAGANOV KD, BOLDIN MP, CHANG KJ, et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006; 103(33):12481-12486.
[61] POLYTARCHOU C, HOMMES DW, PALUMBO T, et al. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice. Gastroenterology. 2015;149(4):981-992.
|